Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Man threatens attack on German high-speed train, 12 lightly injured - 2Pfizer in $41.5 million settlement with Texas over ADHD drug for children
- 3SpaceX's 1st 'Version 3' Super Heavy Starship booster buckles under pressure during initial tests
- 4Jenny & Dave Marrs Mourn Loss of Former ‘Fixer to Fabulous: Italiano’ Guest
- 5Overseeing Individual budgets Successfully
- Shredded cheese recall: Multiple brands sold at Aldi, Target and Walmart affected over potential metal fragment contamination
- 'A completely new manufacturing frontier': Space Forge fires up 1st commercial semiconductor factory in space
- Make your choice for a definitive Christmas getaway destination!
- A Couple of Modest Guitars for 2024
- Must-See Attractions in France
- ‘Integral part of our nation’: Herzog visits Franciscan Sisters in Jerusalem ahead of Christmas
- Figure out How to Establish a long term connection with Your Handshake
- Zelensky sees win for Ukraine as EU finally reaches funding deal
- Astronomers discover never-before-seen celestial object: "Cloud 9"
